Frailty Is Independently Associated with Mortality and Readmission in Hospitalized Patients with Inflammatory Bowel Diseases

被引:54
作者
Qian, Alexander S. [1 ]
Nguyen, Nghia H. [1 ]
Elia, Jessica [2 ]
Ohno-Machado, Lucila [3 ]
Sandborn, William J. [1 ]
Singh, Siddharth [1 ,3 ]
机构
[1] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Expert Rehabil Serv, La Jolla, CA 92093 USA
[3] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA
关键词
Ageing; Prognostic; Infection; Crohn's Disease; Colitis; OLDER PATIENTS; OUTCOMES; INFECTIONS; MANAGEMENT; METAANALYSIS; CHALLENGES; RISK;
D O I
10.1016/j.cgh.2020.08.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Old age must be considered in weighing the risks of complications vs benefits of treatment for patients with inflammatory bowel diseases (IBD). We conducted a nationally representative cohort study to estimate the independent effects of frailty on burden, costs, and causes for hospitalization in patients with IBD. METHODS: We searched the Nationwide Readmissions Database to identify 47,402 patients with IBD, hospitalized from January through June 2013 and followed for readmission through December 31, 2013. Based on a validated hospital frailty risk scoring system, 15,507 patients were considered frail and 31,895 were considered non-frail at index admission. We evaluated the independent effect of frailty on longitudinal burden and costs of hospitalization, inpatient mortality, risk of readmission and surgery, and reasons for readmission. RESULTS: Over a median follow-up time of 10 months, adjusting for age, sex, income, comorbidity index, depression, obesity, severity, and indication for index hospitalization, frailty was independently associated with 57% higher risk of mortality (adjusted hazard ratio [aHR], 1.57; 95% CI, 1.34-1.83), 21% higher risk of all-cause readmission (adjusted hazard ratio [HR], 1.21; 95% CI, 1.17-1.25), and 22% higher risk of readmission for severe IBD (aHR, 1.22; 95% CI, 1.16-1.29). Frail patients with IBD spent more days in the hospital annually (median 9 days; interquartile range, 4-18 days vs median 5 days for non-frail patients; interquartile range, 3-10 days; P < .01) with higher costs of hospitalization ($17,791; interquartile range, $8368-$38,942 vs $10,924 for non-frail patients, interquartile range, $5571-$22,632; P < .01). Infections, rather than IBD, were the leading cause of hospitalization for frail patients. CONCLUSIONS: Frailty is independently associated with higher mortality and burden of hospitalization in patients with IBD; infections are the leading cause of hospitalization. Frailty should be considered in treatment approach, especially in older patients with IBD.
引用
收藏
页码:2054 / +
页数:24
相关论文
共 31 条
[1]   The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J].
Alatab, Sudabeh ;
Sepanlou, Sadaf G. ;
Ikuta, Kevin ;
Vahedi, Homayoon ;
Bisignano, Catherine ;
Safiri, Saeid ;
Sadeghi, Anahita ;
Nixon, Molly R. ;
Abdoli, Amir ;
Abolhassani, Hassan ;
Alipour, Vahid ;
Almadi, Majid A. H. ;
Almasi-Hashiani, Amir ;
Anushiravani, Amir ;
Arabloo, Jalal ;
Atique, Suleman ;
Awasthi, Ashish ;
Badawi, Alaa ;
Baig, Atif A. A. ;
Bhala, Neeraj ;
Bijani, Ali ;
Biondi, Antonio ;
Borzi, Antonio M. ;
Burke, Kristin E. ;
Carvalho, Felix ;
Daryani, Ahmad ;
Dubey, Manisha ;
Eftekhari, Aziz ;
Fernandes, Eduarda ;
Fernandes, Joao C. ;
Fischer, Florian ;
Haj-Mirzaian, Arvin ;
Haj-Mirzaian, Arya ;
Hasanzadeh, Amir ;
Hashemian, Maryam ;
Hay, Simon, I ;
Hoang, Chi L. ;
Househ, Mowafa ;
Ilesanmi, Olayinka S. ;
Balalami, Nader Jafari ;
James, Spencer L. ;
Kengne, Andre P. ;
Malekzadeh, Masoud M. ;
Merat, Shahin ;
Meretoja, Tuomo J. ;
Mestrovic, Tomislav ;
Mirrakhimov, Erkin M. ;
Mirzaei, Hamed ;
Mohammad, Karzan A. ;
Mokdad, Ali H. .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01) :17-30
[2]   Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities [J].
Ananthakrishnan, Ashwin N. ;
Donaldson, Tamara ;
Lasch, Karen ;
Yajnik, Vijay .
INFLAMMATORY BOWEL DISEASES, 2017, 23 (06) :882-893
[3]   Inflammatory Bowel Disease in the Elderly Is Associated With Worse Outcomes: A National Study of Hospitalizations [J].
Ananthakrishnan, Ashwin N. ;
McGinley, Emily L. ;
Binion, David G. .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (02) :182-189
[4]   The Challenges of Managing Inflammatory Bowel Diseases in Older Patients [J].
Asscher, Vera E. R. ;
van der Meulen-De Jong, Andrea E. ;
Mooijaart, Simon P. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (07) :1648-1649
[5]   Systematic Review: Components of a Comprehensive Geriatric Assessment in Inflammatory Bowel Disease-A Potentially Promising but Often Neglected Risk Stratification [J].
Asscher, Vera E. R. ;
Lee-Kong, Felicia V. Y. ;
Kort, Esther D. ;
van Deudekom, Floor J. ;
Mooijaart, Simon P. ;
Maljaars, P. W. Jeroen .
JOURNAL OF CROHNS & COLITIS, 2019, 13 (11) :1418-1432
[6]   International variation in medication prescription rates among elderly patients with inflammatory bowel disease [J].
Benchimol, Eric I. ;
Cook, Suzanne F. ;
Erichsen, Rune ;
Long, Millie D. ;
Bernstein, Charles N. ;
Wong, Jenna ;
Carroll, Charlotte F. ;
Froslev, Trine ;
Sampson, Tim ;
Kappelman, Michael D. .
JOURNAL OF CROHNS & COLITIS, 2013, 7 (11) :878-889
[7]   Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis [J].
Borren, Nienke Z. ;
Ananthakrishnan, Ashwin N. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) :1736-+
[8]   Oral Corticosteroids and the Risk of Serious Infections in Patients With Elderly-Onset Inflammatory Bowel Diseases [J].
Brassard, Paul ;
Bitton, Alain ;
Suissa, Alain ;
Sinyavskaya, Liliya ;
Patenaude, Valerie ;
Suissa, Samy .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 (11) :1795-1802
[9]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[10]   Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease [J].
Cottone, Mario ;
Kohn, Anna ;
Daperno, Marco ;
Armuzzi, Alessandro ;
Guidi, Luisa ;
D'Inca, Renata ;
Bossa, Fabrizio ;
Angelucci, Erika ;
Biancone, Livia ;
Gionchetti, Paolo ;
Ardizzone, Sandro ;
Papi, Claudio ;
Fries, Walter ;
Danese, Silvio ;
Riegler, Gabriele ;
Cappello, Maria ;
Castiglione, Fabiana ;
Annese, Vito ;
Orlando, Ambrogio .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (01) :30-35